SYNOVUS FINANCIAL CORP - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 176 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2020$8,000
+100.0%
1080.0%0.00%
Q1 2020$4,000
-33.3%
1080.0%0.00%
Q4 2019$6,000
+20.0%
1080.0%0.00%
Q3 2019$5,0000.0%1080.0%0.00%
Q2 2019$5,000
-16.7%
1080.0%0.00%
Q1 2019$6,000
+50.0%
1080.0%0.00%
Q4 2018$4,0000.0%1080.0%0.00%
Q3 2018$4,0001080.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 450,422$6,251,85714.11%
Liontrust Investment Partners LLP 134,659$7,478,9610.13%
Birchview Capital, LP 7,365$1020.07%
FNY Investment Advisers, LLC 250$30.00%
FNY Investment Advisers, LLC 18$00.00%
FNY Investment Advisers, LLC 56$00.00%
McElhenny Sheffield Capital Management, LLC 31$4300.00%
Blue Trust, Inc. 65$100.00%
IFP Advisors, Inc 1$10.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders